Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 10, 1998, Pages 2121-2135

  Poolman, Robert A ^a   Brooks, Gavin ^a,b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b Prolifix Ltd   (United Kingdom)

Author keywords

Cardiac myocyte; Cyclin; Cyclin dependent kinase; Cyclin dependent kinase inhibitor; Rat

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; HISTONE H1; PROTEIN P21; PROTEIN P27;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL HYPERPLASIA; FEMALE; FLUORESCENCE ACTIVATED CELL SORTER; HEART VENTRICLE HYPERTROPHY; IMMUNOBLOTTING; MALE; MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0032191632     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0808     Document Type: Article

References (37)

1. BRADFORD MM, 1976. A rapid and sensitive method for quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72: 248-254.
2. BROOKS G, POOLMAN RA, MCGILL CJ, LI J-M, 1997. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes. J Mol Cell Cardiol 29: 2261-2271.
3. BURTON PBJ, YACOUB MH, BARTON PJR, 1997. Cell cycle regulatory molecule expression during heart development. J Mol Cell Cardiol 29: A41.
4. CAPASSO JM, BRUNO S, CHENG W, LI P, RODGERS R, DARZYNKIEWICZ Z, ANVERSA P, 1992. Ventricular loading is coupled with DNA synthesis in adult cardiac myocytes after acute and chronic myocardial infarction in rats. Circ Res 71: 1379-1389.
5. FAHA B, EWEN ME, TSAI L-H, LIVINGSTON DM, HARLOW E, 1992. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science 255: 87-90.
6. FLINK IL, OANA S, MAITRA N, BAHL JJ, MORKIN E, 1998. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes. J Mol Cell Cardiol 30: 563-578.
7. FLINK IL, OANA S, BAHL JJ, MORKIN E, 1996. Terminal differentiation in cardiomyocytes results from hypophosphorylation of retinoblastoma protein by induction of cyclin-dependent kinase inhibitory activities. Circ 94: A2745.
8. GUNN MD, SEN A, CHANG A, WILLERSON JT, BUJA LM, CHIEN KR, 1985. Mechanisms of accumulation of arachadonic acid in cultured myocardial cells during ATP depletion. Am J Physiol 249: H1188-H1194.
9. HORKY M, KUCHTICKOVA S, VOJTESEK B, KOLAR F, 1997. Induction of cell-cycle inhibitor p21 in rat ventricular myocytes during early postnatal transition from hyperplasia to hypertrophy. Physiol Res 46: 233-235.
10. KANG MJ, KIM I, TERHUNE A, CHAE SW, KOH GY, 1996. The concurrent disappearance of mitotic cyclins and formation of binucleation in neonatal cardiomyocytes. Circ 94: A2826.
11. KANG MJ, KIM J-S, CHAE S-W, KOH KN, KOH GY, 1997. Cyclins and cyclin dependent kinases during cardiac development. Mol Cells 7: 360-366.
12. KANG MJ, KOH GY, 1997. Differential and dramatic changes of cyclin-dependent kinase activities in cardiomyocytes during the neonatal period. J Mol Cell Cardiol 29: 1767-1777.
13. 1-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem 270: 410-417.
14. KIM SJ, LEE H-D, ROBBINS PD, BUSAM K, SPORN MB, ROBERTS AB, 1991. Regulation of transforming growth factor β1 gene expression by the product of the retinoblastoma susceptibility gene. Proc Natl Acad Sci USA 88: 3052-3056.
15. KIM S-J, ONWUTA US, LEE YI, LI R, BOTCHAN MR, ROBBINS PD, 1992. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol Cell Biol 12: 2455-2463.
16. KIM KK, SOONPAA MH, DAUD AI, KOH GY, KIM JS, FIELD LJ, 1994. Tumor suppressor gene expression during normal and pathologic myocardial growth. J Biol Chem 269: 22607-22613.
17. KIP1, in rat hearts during development. J Mol Cell Cardiol 30: 463-474.
18. KREK W, EWEN ME, SHIRODKAR S, ARANY Z, KAELIN WG, LIVINGSTON DM, 1994. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172.
19. KREK W, XU G, LIVINGSTON DM, 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83: 1149-1158.
20. LABAER J, GARRETT MD, STEVENSON LF, SLINGERLAND JM, SANDHU C, CHOU HS, FATTAEY A, HARLOW E, 1997. New functional activities for the p21 family of CDK inhibitors. Genes Devel 11: 847-862.
21. LI F, WANG X, CAPASSO JM, GERDES AM, 1996. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol 28: 1737-1746.
22. LI J-M, BROOKS G, 1997. Down-regulation of the cyclin dependent kinase inhibitors, p21 and p27, in pressure overload hypertrophy. Am J Physiol 273: H1358-H1367.
23. LI J-M, POOLMAN RA, BROOKS G, 1998. Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats. Am J Physiol 275: H814-H822.
24. MCGILL CJ, BROOKS G, 1995. Cell cycle control mechanisms and their role in cardiac growth. Cardiovasc Res 30: 557-569.
25. MCGILL CJ, POOLMAN RA, BROOKS G, 1996. Expression of cell cycle molecules during development of rat cardiac myocytes. J Mol Cell Cardiol 28: A76.
26. MOLKENTIN JD, LU J-R, ANTOS CL, MARKHAM B, RICHARDSON J, ROBBINS J, GRANT SR, OLSON EN, 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228.
27. MORGAN HE, GORDON EE, KIRA Y, CHUA BHL, RUSSO LA, PETERSON CJ, MCDERMOTT PJ, WATSON PA, 1987. Biochemical mechanisms of cardiac hypertrophy. Ann Rev Physiol 49: 533-543.
28. OHTSUKI F, YAKAMOTO M, NAKAGAWA T, TANIZA WA, WADA H, 1997. Granulocyte-macrophage colony-stimulating factor abrogates transforming growth factor-β1-mediated cell cycle arrest by up-regulating cyclin D2/CDK6. Br J Haem 98: 520-527.
29. POOLMAN RA, BROOKS G, 1996. Expression of CIP/KIP family of cyclin-dependent kinase inhibitors during cardiac development. Circ 94: A0909.
30. SADOSHIMA J, AOKI H, IZUMO SI, 1997. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ Res 80: 228-241.
31. SOONPAA MH, KIM KK, PAJAK L, FRANKLIN M, FIELD LJ, 1996. Cardiomyocyte DNA synthesis and binucleation during murine development. Am J Physiol 271: H2183-H2189.
32. TAM SKC, GU W, MAHDAVI V, NADAL-GINARD B, 1993. Tumor suppressor genes and cell cycle regulators expression in cardiac development and hypertrophy. Circ 88: 1-240.
33. UDVADIA AJ, ROGERS KT, HIGGINS PDR, MURATA Y, MARTIN H, HUMPHREY PA, HOROWITZ JM, 1993. Sp-1 binds promoter elements regulated by the RB protein and Sp-1 mediated transcription is stimulated by RB expression. Proc Natl Acad Sci USA 90: 3265-3269.
34. YOSHIZUMI M, LEE W-S, HSIEH C-M, TSAI J-C, LI J, PERELLA MA, PATTERSON C, ENDEGE WO, SCHLEGEL R, LEE M-E, 1995. Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts. J Clin Invest 95: 2275-2280.
35. KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol 17: 407-415.
36. ZHANG H, HANNON GJ, BEACH D, 1994. p-21 containing cyclin kinases exist in both active and inactive states. Genes Devel 8: 1750-1758.
37. ZHANG T, NANNEY LB, PEELER MO, WILLIAMS CS, LAMPS L, HEPPNER KJ, DUBOIS RN, BEAUCHAMP RD, 1997. Decreased transforming growth factor β type II receptor expression in intestinal adenomas from Min1 + mice associated with increased cyclin D1 and cyclin-dependent kinase 4 expression. Canc Res 57: 1638-1643.